Counting The Cost Of Marks & Spencer’s Cyber-attack, And AstraZeneca Versus GSK AJ Bell Money & Markets podcast

Content provided by AJ Bell. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by AJ Bell or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

AJ Bell Money & Markets »
Counting the cost of Marks & Spencer’s cyber-attack, and AstraZeneca versus GSK

6d ago 53:58

MP3•Episode home

On this week’s AJ Bell Money & Markets podcast, Dan Coatsworth and Tom Sieber explore some big names on the UK and US stock market following a spate of corporate updates over the past week. They chat about Guinness maker Diageo, sausage roll giant Greggs, and a trio of American firms which have given us a fascinating insight into the state of the US consumer. [6:05]

Marks & Spencer has laid out the potential hit to profits from its recent cyber-attack and it’s a hefty sum. Dan has all the details and he talks to fund manager Ian Lance from Temple Bar Investment Trust to get a shareholder’s perspective on the incident. [14:30]

Hear about the new threat to Next and Dunelm as a US home furnishings giant prepares to make its UK debut. [21:15]

Dan chats about an important development in the buy now, pay later industry [25:20] and why there is some relief for certain victims of scams. [29:20]

Tom has a fascinating insight into the UK property market as more Americans look to move to the UK. [32:05]. Tom also talks about big moves in the cash savings market. [34:50]

Finally, don’t miss the second part of our interview with Edinburgh Investment Trust’s Emily Barnard who explains how AstraZeneca differs from GSK, key achievements from both companies, and where they might go next. [37:30]

335 episodes

#AJ Bell #Personal Finances #Lifestyle #Stock Market #Trading #Business